Get the latest delivered to your inbox
Privacy Policy

Now Reading

Alkermes’ Katie Joyce To Speak at Women in Bio 2023

Alkermes’ Katie Joyce To Speak at Women in Bio 2023

Published 04-25-23

Submitted by Alkermes

Headshot of Katie Joyce on a blue background with the text "Panelist: Women in Bio, Management Track"

Last week, Katie Joyce, VP of Corporate Affairs, participated in a panel discussion at this year's Women in Bio (WIB) Management Track event featuring women leaders in life science. This year’s event gave attendees the opportunity to connect with industry leaders and hear from a panel of executive women leaders discussing their career paths and individual experiences. To learn more about Women In Bio, visit their website:

Alkermes logo



Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at

More from Alkermes

Join today and get the latest delivered to your inbox